Key Takeaways: Program-level review helps identify where resources are stretched and which programs need strategic attention. Combining financial results with mission contribution supports intentional, data-informed...
Key takeaways: IRS updates FAQs on business interest expense deductions under Section 163(j). New rules allow adding back depreciation, amortization, and depletion when calculating adjusted...
When preparing a business for sale, one of the first areas buyers examine is tax compliance. Where a company files state income, sales, and payroll...
Life sciences companies face some of the highest costs and longest timelines for research and development. The One Big Beautiful Bill (OBBB) Act, with the...
Understanding the U.S. Market Entry Process for Life Science Companies For foreign life sciences companies, the decision to establish a presence in the United States...
Cash drives every strategic decision in the life sciences and medical device field. Whether investing in research and development spending, advancing a therapy through clinical...
In this article: Adapting to Investor Caution Planning for Multiple Scenarios Rethinking Capacity and Structures Upgrading What You Already Have Staying Ready for the Next...
In the life sciences sector, where innovation often relies on grant funding, financial stability has become increasingly uncertain. Federal budget constraints and shifting political priorities...
In this article: The Importance of R&D Tax Credits and Financial Planning Best Practices, Budgeting, Technology, and Vendor Terms Accounting Clean-Up for Improved Financial Management...
